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Introduction: Acute aortic dissection (AAD) is one of the most common aortic emergencies that vascular specialists are
asked to manage. Traditional surgical interventions for cases complicated by malperfusion have resulted in significant
morbidity and mortality. With increasing availability of thoracic endografts, endovascular interventions for complicated
AAD have become more acceptable. We reviewed our experience with endovascular treatment of AAD since January 2005.
Methods: Medical records of patients admitted for AAD from January 1, 2005, to December 31, 2008, were entered into
our vascular registry and analyzed for risk factors, extent of dissection, type of management, fate of the false lumen,
complications, and survival. There were 249 admissions for aortic dissections during the study period. Our study group
included 28 patients with complicated AAD who underwent endovascular intervention.
Results: During the study interval, 28 patients (16 male) underwent 44 procedures. The average age was 54 years. Risk
factors differed from the typical atherosclerotic patient and were dominated by an 89.3% incidence of hypertension. Five
patients (17.9%) presented with a history of recent cocaine use. The average length of stay was 25.1 days (range, 1-196
days). Stanford type B dissections were present in all but one patient. Twenty-six thoracic endografts were placed in 25
patients. Eight patients required multiple procedures in addition to a thoracic endograft. Morbidity occurred in 17
(60.7%) patients, with renal insufficiency occurring in 11 patients (39.3%) and one requiring permanent dialysis. Four
neurologic events occurred: three strokes (10.7%) and one patient (3.6%) with temporary paraplegia. Three patients
(10.7%) died in the periprocedural period, with ruptured dissection in one and pericardial tamponade in another. Eight
of 10 computed tomography scans (80%) available for review in follow-up showed complete thrombosis of the thoracic
false lumen.
Conclusions: Complicated AAD remains a challenging problem, with significant morbidity and mortality rates. However,
our early experience with endovascular management offers a favorable reduction in mortality from historic controls.
(J Vasc Surg 2011;54:1283-9.)
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wAcute aortic dissection (AAD) is one of the most fre-
quent aortic emergencies that confronts the vascular spe-
cialist.1 Most are Stanford type A, and early surgery is well
established as the preferred treatment.2 Type A dissections
with distal extension have higher mortality rates.3 The
treatment of Sanford type B dissections has been largely
medical, with surgical intervention reserved for patients
developing complications. Mortality has been 8% to 10%
for medical management and 21% to 34% for surgical
treatment.1,4-6 Interventional options for the treatment of
complicated type B AAD during the last 2 decades have
changed the landscape, and numerous reports have dem-
onstrated significant improvement in mortality rates com-
pared with open surgery.7-9
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doi:10.1016/j.jvs.2011.04.025With the recognition that exclusion of the entry tear
eliably restores the true lumen pressure and that thoracic
ndografts are available to accomplish this goal, vascular
urgeons have found themselves increasingly involved in
he management of AAD with distal extension.10,11 This is
lso true for type A dissections with distal extension, with
ndovascular techniques being used in this group as
ell.12,13 We have used endovascular methods for treating
omplicated type A and B AADs since 2005, and this report
etails our experience with the management of AAD since
hat time.
ETHODS
Patients. Medical records of patients admitted for
AD from January 1, 2005, to December 31, 2008, were
ntered into our vascular registry and analyzed for risk
actors, extent of dissection, type of management, fate of
he false lumen, complications, and survival. There were
49 admissions for aortic dissections during the study
eriod. In July 2005, an acute aortic service was estab-
ished, with treatment protocols for acute aortic pathology.
he cardiac surgery and vascular surgery services both
dmitted patients, with the other service consulting. Our
tudy group included 28 patients with complicated AAD
ho underwent endovascular intervention.
Indications. All patients with type A AAD were re-
erred emergently for surgical repair. If the aorta distal to
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November 20111284 O’Donnell et althe subclavian artery was involved, the patient was assessed
for evidence of visceral or extremity ischemia and, if pres-
ent, was treated with endovascular interventions. All pa-
tients with type B AAD with evidence of malperfusion
shown by overt visceral or extremity ischemia underwent
urgent endovascular intervention.
All patients with type B AAD were admitted to the
surgical intensive care unit and initially managed with a
standing protocol for medical management of AAD and
observed for evidence of visceral or extremity malperfusion.
Patients with evidence of malperfusion who did not re-
spond to medical management underwent endovascular
intervention. Rising serum lactate levels, persistent abdom-
inal pain, inability to advance to an oral diet, rising serum
creatinine levels, and inability to wean intravenous antihy-
pertensive medication were all considered evidence of per-
sistent malperfusion. Pain alone was not used as an indica-
tion for endovascular intervention.
Procedural techniques. The principle goals of endo-
vascular management are:
1. Establish access to the true lumen.
2. Cover the entry tear with an endograft. The Gore TAG
(W. L. Gore and Associates, Flagstaff, Ariz) was used as
the endograft to cover the entry site in all patients
during this study period.
3. Correct any static or dynamic obstruction to the aortic
true lumen and the visceral, renal, and lower extremity
arteries (Fig 1).
Frequently, after accomplishing the first and second
goals of covering the aortic entry tear, the third goal was
fulfilled by a windsock effect when true lumen flow was
restored. Stents were not placed in fenestrated visceral
orifices unless a significant static or dynamic obstruction
was noted.
Intravascular ultrasound (IVUS) was used in all pa-
tients as an aid in identifying the anatomy and gaining
access to the true lumen. Endografts were sized by two
anatomic measurements made on the admission computed
tomography (CT) scan and intraoperative IVUS: the diam-
eter of the normal aorta proximal to the dissection and the
diameter of the crescent formed by the true lumen collapse
in the descending aorta. Adequate true lumen and visceral
flow was verified by completion angiography and IVUS.
No attempt was made to completely exclude the false
lumen.
Medical management was continued after the proce-
dure, and patients were weaned to oral antihypertensive
agents. Spinal drainage was not used prophylactically but
was instituted emergently if evidence of lower extremity
weakness developed.
Access for endograft delivery was primarily a femoral
cutdown and confirmation of true-lumen position. Al-
though not required in this series, we do not hesitate to use
a limited retroperitoneal approach to the iliac artery for
device delivery if the external iliac artery is not clearly
suitable. The contralateral femoral artery is usually ac-
cessed percutaneously for diagnostic angiography and endograft positioning and also with caution to ensure
rue lumen position. Left brachial artery access was oc-
asionally used to establish the true lumen position and
ndograft positioning.
Statistical analysis. The statistical software that is part
f our clinical database was used to perform life-table
nalysis using the Kaplan-Maier technique and bivariant
nalysis in addition to the descriptive statistics of the group.
isk factors were compared with the outcome of death by
sing the log-rank test for bivariant analysis.
Follow-up. Our clinical database and hospital records
ere used to determine patient status and length of follow-
p. CT scans were routinely performed at 3 months, 6
onths, and yearly after the intervention. Survival, false
umen thrombosis, and aortic measurements were reviewed
hen available.
ESULTS
Demographics. During the study period, 249 patients
ere admitted with an AAD, and 28 (16 men) underwent
ndovascular interventions. The average age was 54 years.
isk factors differed from the typical atherosclerotic patient
nd were dominated by an 89.3% incidence of hypertension
Table I). Five patents (17.9%) presented with a history of
ecent cocaine use. The average length of stay was 25.1 days
range, 1-196; mode, 7 days).
Stanford type B dissections were present in all but one
atient. The patient with a type A dissection is worth special
ention. This patient presented with distal extension and
rofound visceral and lower extremity ischemia. After con-
iderable discussion, this patient underwent endograft cov-
able I. A, Demographics
Age Type
ariable No. Mean  SD Procedures A B
ale 16 51  14.4 23 1 15
emale 12 58  14.7 21 0 12
otal 28 54  14.7 44 28
D, Standard deviation.
able I. B, Comorbidities
ariable Yes (n) No (n) %
ardiac 0 28 0
ypertension 25 3 89.3
moking 10 18 35.7
yperlipidemia 3 25 10.7
ulmonary 0 28 0
enal 4 24 14.3
AD 0 28 0
erebral 2 26 7.1
iabetes 4 24 14.3
ocaine 5 23 17.9
besity 2 26 7.1
AD, Peripheral arterial disease.rage of the entry site in the proximal descending thoracic
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Volume 54, Number 5 O’Donnell et al 1285aorta, with resolution of his ischemia. Repair of his ascend-
ing aorta was deferred because of myoglobinuria and renal
insufficiency. The patient died suddenly on postoperative
day 3, and the postmortem examination revealed pericar-
dial tamponade as the cause of death.
Interventions. The 28 patients underwent 43 endo-
Fig 1. Drawings show how side branches are affected b
tion. C, Dynamic obstruction.
Table II. Endovascular procedures performed
Procedure No.
Thoracic endograft 26a
Renal stent 9
Celiac stent 1
Superior mesenteric artery stent 1
Iliac stent 5
Aortic stent 1
Total 43b
aEight patients required mesenteric, renal, or iliac artery stenting in addition
to the endograft.
bSix procedures were performed on two patients during follow-up.vascular procedures. One patient had a left carotid to subclavian artery bypass for a total of 44 procedures during
he study period. All patients were initially treated during
he acute phase, defined as 2 weeks after the onset of
AD.1 Three patients were treated with endovascular
te aortic dissections. A, Static obstruction. B, Fenestra-
able III. Complications
No. (%)
omplication (n  28) Outcome
enal failure 11 (39.3%) 1 permanent dialysis
troke 3 (10.7) 1 permanent deficit
ntestinal ischemia 2 (7.1) 1 colon resection
ardiac arrest 1 (3.6) Died
ortic rupture 1 (3.6) Died
ericardial tamponade 1 (3.6) Died
ymphocele 1 (3.6) Resolved
espiratory failure 1 (3.6) Ventilator-dependant
araplegia 1 (3.6) Resolved
otal 22 in 17 (60.7) ptsy acutenting without a thoracic endograft. Time to treatment
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November 20111286 O’Donnell et alaveraged 2.9 days, ranging from day of admission to 10
days. Seven patients (25%) were treated in24 hours, eight
were treated 24 to 48 hours after admission, and 13 were
treated after the second day of admission. Of the seven
treated in24 hours, the average time to treatment was 4.8
hours (range, 1-10.5 hours). These patients had severe
visceral malperfusion, and one patient also had an ischemic
lower extremity.
A total of 26 thoracic endograft procedures were per-
formed in 25 patients (Table II). The left subclavian was
covered in four patients. Ten patients (35.7%) required 12
additional interventions during the initial hospitalization, 8
patients at the same time as the thoracic endograft, which
included seven renal, two superior mesenteric, one celiac,
and two aortic stents. Three patients did not have thoracic
endografting. These included two patients who received an
isolated renal artery stents when intravenous antihyperten-
sives could not be weaned, associated with static renal
artery obstruction. In the other patient, an infrarenal aortic
stent and iliac stent were placed for lower extremity isch-
emia.
Complications. A total of 22 complications occurred
in 17 patients (60.7%). Renal insufficiency occurred in 11
patients (39.3%), with one patient requiring permanent
dialysis (Table III). Four neurologic events occurred, com-
prising three strokes (10.7%), of which two were minor.
Temporary paraplegia developed in one patient (3.6%) after
Fig 2. Life-table shows survival after enan onset of lower extremity weakness on postoperative day e, presumably caused by relative hypotension. The patient
ad a thoracic endograft without coverage of the subclavian
rtery and was treated with spinal drainage for 48 hours and
as able to ambulate at the time of discharge.
Perioperative mortality was 10.7%, with three patients
ying30 days. Causes of death, in one patient each, were
ruptured dissection, cardiac arrest, and pericardial tam-
onade. When death was analyzed by risk factors, age70
as the only significant factor (P  .028). Two patients
ere aged 80, and both died perioperatively.
Two patients (7.1%) had bowel ischemia, and one
equired a colon resection. One was ventilator-dependent
t discharge because of pulmonary failure. Of the 25 pa-
ients who survived the perioperative period, 18 (72%) were
ischarged home, and seven (28%) were discharged to
ehabilitation centers.
Follow-up. The average follow-up was 21 months
range, 1-45 months). Overall survival was 85%, with only
ne death during follow-up (Fig 2). Eight of the 10 CT
cans (80%) available for review in follow-up showed com-
lete thrombosis of the thoracic false lumen. Two patients
7.1%) required elective reinterventions. The indication in
he first patient was short-distance claudication, which was
reated with iliac stenting.
The second patient is of particular interest. A bare-
etal Wallstent (Boston Scientific, Natick, Mass) was
laced across the distal descending thoracic aorta and mes-
cular repair for acute aortic dissections.nteric arteries after a proximal thoracic endograft failed to
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Volume 54, Number 5 O’Donnell et al 1287resolve the true lumen collapse across the visceral segment.
At 5 months after the initial intervention, back pain devel-
oped, associated with recurrent flow in the thoracic false
lumen. This appeared to be caused by separation of the
proximal endograft and the distal stent, resulting in a large
tear in the dissection septum.
The patient’s original endograft covered her left sub-
clavian artery, and the recurrent symptoms were coincident
to the return of her left radial pulse on examination. She
underwent placement of a distal extension to the endograft
that covered the new tear in the septum, along with coiling
of the proximal left subclavian artery (Fig 3). She was again
readmitted with vertebral basilar insufficiency and left hand
numbness, which resolved after a left carotid-to-subclavian
bypass. Endograft erosion through the dissection septum
has been described, mandating long-term follow-up.14,15
This problem may be related to oversizing as well as to
grafts with bare metal extensions.
DISCUSSION
Management of AADs complicated by malperfusion
remains one of the most dreaded conditions faced by
vascular surgeons. Conventional open surgical treatment
has produced poor results, with a mortality rate of 34% in a
recent review from the International Registry of Acute
Aortic Dissection database.6 Although surgery for type A
dissection is the standard of care, mortality is still high, and
patients with distal extension present with challenges that
are similar to those with type B dissections.16,17 For this
reason, we included type A dissections in our review.
Although not included in this study, we have inter-
vened on a number of type A dissections outside of the
Fig 3. Computed tomography angiography at 3 years after rein-
tervention shows distal graft extension.acute period and have made it a practice to evaluate all type tdissections with a distal aortic component immediately
fter the ascending aortic repair. The patient with a type A
issection included in our study, whose details were noted
n the Results, represents a particularly lethal set of ana-
omic features. From our experience and limited data, we
urrently recommend sequential endovascular distal repair,
ollowed by open surgical repair of the ascending and arch
omponents, with as minimal as possible delay between the
wo procedures in patients with visceral or peripheral isch-
mia as the major presenting symptoms.
Cocaine ingestion immediately before the onset of
ymptoms was noted in 17.9% of our patients. This is a
ecognized risk factor described by other reports.18-23 The
apid catecholamine surge after cocaine ingestion, espe-
ially in a patient with poorly treated hypertension, can
esult in AAD. Community awareness of this catastrophic
omplication of cocaine use may be an opportunity that has
ot been emphasized.24
Hypertension continues to be the dominant risk fac-
or.25,26 The cardiac and cerebrovascular complications of
ntreated hypertension have been well recognized, and
ublic awareness of this fact is high. AAD does not enjoy
he same status, however. Vascular specialists as well as
rimary care physicians and physician extenders should
mphasize this point when counseling patients with hyper-
ension.
Thoracic endografts have evolved considerably since
ig 4. Treatment algorithm for acute aortic dissections (AADs).
TA, Computed tomography angiography. *Transesphageal
chocardiogram considered for patients with renal insufficiency.his study. We have more recently favored the available
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November 20111288 O’Donnell et alDacron grafts, which have more reliable proximal position-
ing and less propensity for infolding than the grafts that
were used during this study.27-29 In addition, the new
grafts frequently do not require ballooning, which may
contribute to retrograde dissection and neurologic compli-
cations. Although supporting data are limited, proximal
positioning of the endograft in normal aorta may reduce
retrograde dissection.
For this reason, and the imperative to perform all
interventions from within the true lumen, we have found
the use IVUS mandatory. Instances of the wire starting in
the true lumen and ending up in the false lumen have
occurred; if unrecognized, this could prove disastrous. It is
essential to ensure wire access in the true lumen from the
femoral artery to the ascending thoracic aorta, because
placement of an endograft in the false lumen could occlude
the true lumen, and endovascular salvage would be ex-
tremely difficult, if not impossible. Multiple tears and reen-
try sites are traps for the unexpecting operator to think he
or she has access in the true lumen, only to find that part
way up the aorta, the wire has gone through a secondary
tear and into the false lumen.
The length of dissected aorta that requires endograft-
ing is unknown.14 The initial goal of treatment is to correct
malperfusion. Prevention of aneurysmal dilatation awaits
further data, and with paraplegia being a continuing con-
cern, as seen in this series, it is not unreasonable to continue
with a conservative approach and treat the length required
to resolve malperfusion.30 This same logic applies to the
treatment of visceral and lower extremity arteries involved
in the dissection. In our series, 35.7% of patients underwent
additional branched artery interventions with the goal of
doing only what was necessary to correct malperfusion and
not just to restore normal anatomy.
Although the long-term outcome of AAD treated with
endovascular approaches is waiting further study, the dra-
matic difference between surgical and endovascular treat-
ments for complicated AAD would seem to justify the
continued use of an endovascular approach in these pa-
tients.6 Our current treatment algorithm is shown in Fig 4.
We use CT angiography as our first-line imaging modality
to confirm the diagnosis of AAD and determine the extent.
The only exception to this are patients who present with
renal insufficiency and creatinine levels 2.0 mg/dL. In
these instances, we often use transesophageal echo to dis-
Table IV. Comparison of series using endovascular treatm
Follow-up M
First author Year No. (months)
Alves31 2009 73 35.9
Feezor32 2009 33
Khoynezhad33 2009 28 36
O’Donnell 2011 28 21
Patel34 2009 69
Chang7 2008 47 28.2tinguish between type A and B dissections. If a type A is Ween on echo, then those patients go directly to the oper-
ting room for an ascending aortic repair. If a type B
issection is seen and the patient requires urgent interven-
ion, we use IVUS to determine the extent of distal aortic
nvolvement and use contrast only as needed for the cor-
ection of the malperfusion. The patients who require
mergency repair of their type A dissections are evaluated
mmediately after the repair for resolution of any visceral or
xtremity ischemia. If present, they are treated by endovas-
ular interventions.
The results of recent series also appear to justify an
ndovascular approach first for the treatment of the tho-
acic and abdominal component of AAD (Table IV).7,31-34
lthough it is often difficult to compare retrospective se-
ies, we tried to identify common ground in contemporary
eports (Table IV). The average rates for mortality and
orbidity approach that of medical management.1 Al-
hough the midterm results reported in this article appear
avorable, the long-term benefits with regard to aneurysmal
rogression and aortic-related deaths may not prove to be
s beneficial as the management of the acute malperfusion
tates.35
ONCLUSIONS
Complicated AAD remains a challenging problem with
ignificant morbidity and mortality. However, our early
xperience with endovascular management offers a favor-
ble reduction in mortality rates from historical controls.
ppropriately applied endovascular interventions may pro-
ide similar mortality to that of medical management. The
igh incidence of additional procedures at presentation,
uring initial hospitalization, and after discharge places a
articular importance on imaging to delineate the anatomy
nd close follow-up of patients with AAD throughout their
ourse for successful outcomes. The success of endovascu-
ar interventions in preventing long-term aortic-related
eaths will require further investigation.
The authors especially thank Shawn McMahon for his
rtwork in Fig 1.
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